Clinical trial
An Open-label Observational Safety Study During Administration of Topiramate, for the Prophylaxis of Migraine
NCT00297336 is registered in ClinicalTrials.gov with Janssen Cilag Pharmaceutica S.A.C.I., Greece as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Observational Safety Study During Administration of Topiramate, for the Prophylaxis of Migraine
- Lead sponsor
- Janssen Cilag Pharmaceutica S.A.C.I., Greece
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- February 28, 2007
- Enrollment
- 80 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.